Tag: tissue microarray market strategy

  • The Future of theThyroid Cancer Diagnostics Market: Growth Trends, Market Size, and Opportunities to Watch

    The Future of theThyroid Cancer Diagnostics Market: Growth Trends, Market Size, and Opportunities to Watch

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    What Major Innovations Are Driving the Accelerated Growth of the Tissue Microarray Market?

    The tissue microarray market is anticipated to grow due to the rising incidence of cancer. Cancer is a group of diseases that occurs when aberrant cells in any organ or tissue multiply uncontrollably, going beyond their usual limits, and either invade nearby parts of the body or spread to other organs. Tissue arrays are employed in oncology to investigate the presentation of cancer-related biomarkers in numerous tumor samples. For instance, Macmillan Cancer Support, a UK-based cancer charity, reported in June 2022 that the cancer population had hit 3 million in 2022 and was expected to increase to almost 3.5 million by 2025 and 4 million by 2030 in the UK. Hence, the increasing prevalence of cancer is fueling the expansion of the tissue microarray market.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

    #How Does the ProjectedTissue Microarray Market Growth Compare Over the Forecast Period?

    The market for tissue microarrays has seen robust growth in the past few years. The market size is projected to increase from $12.05 billion in 2024, reaching a value of $13.23 billion in 2025, with a compounded annual growth rate (CAGR) of 9.8%. Factors contributing to this historic growth include the advancement of precision medicine, drug discovery and development, effective analysis, an increase in chronic diseases, and initiatives in biobanking.

    In the coming years, the tissue microarray market size is predicted to experience rapid expansion. The market is projected to reach $20.95 billion in 2029, with a compound annual growth rate (CAGR) of 12.2%. This upswing during the forecast period can be linked to the rise of digital pathology, increase in applications, growth of the biopharmaceutical industry, regulatory backing and standards, as well as the incorporation of AI and machine learning. Key trends during this forecasted period include progression in imaging technologies, creation of 3D tissue microarrays, high-content screening, initiatives towards standardization, and the integration of single-cell analysis.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12236

    What Are the Most Significant Market Trends Transforming theTissue Microarray Market?

    Strategic collaborations are becoming a crucial trend in the tissue microarray market, with significant companies in the sector partnering up to foster relationships dedicated to advancing tissue microarray technologies. For example, in November 2022, The Cureline Group, a US-based precision and translational medicine CRO known for its HBS biobanking and lab services, established a partnership with Cellecta Inc., a US company specializing in RNAi and CRISPR screening products and services. The partnership, known as Tissue 2 Target Services, meshes the unique strengths of both companies in the realms of molecular cell and tissue analysis and human biospecimen management, providing specialized services in pre-clinical and translational research focusing on gene target and biomarker discovery services to streamline workflows. Furthermore, in September 2022, Ultivue Inc., a US biotech company that creates reagent-based solutions that enhance the amount of biological information obtainable from cell and tissue samples, teamed up with Switzerland’s ngTMA, the Translational Research Unit (TRU) platform of the University of Bern known for its innovative tissue microarray construction workflows. The collaboration aims to push forward multiplexed immunofluorescence (mIF) assays and introduce fresh TMA technologies for amplified spatial analysis in scientific studies and improving the quality of TMAs applied in clinical and translational research.

    What Are the Top Market Players Propelling the Growth of theTissue Microarray Industry?

    Major companies operating in the tissue microarray market include Roche Group, Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton, Dickinson Biosciences, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, PerkinElmer Inc., Bio-Techne Corporation, Tristar Group, Evotec SE, Precision For Medicine Inc., Molecular Devices LLC, BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co, 3DHISTECH Ltd., Novus Biologicals LLC, PREMIER Biosoft International Inc., iSpecimen Inc., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., Z Biotech LLC

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

    Which Primary Segments of the Tissue Microarray Market Are Driving Growth and Industry Transformations?

    The tissue microarray market covered in this report is segmented –

    1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types

    2) By Technology: Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting

    3) By Application: Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics

    4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals

    Subsegments:

    1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry

    2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH

    3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array

    4) By Other Types: Nucleic Acid Microarrays, RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=12236&type=smp

    Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Tissue Microarray Market?# Market?

    North America was the largest region in the tissue microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Reports Similar to the Gobal Tissue Microarray Maret 2025, By The Business Research Company:

    Computed Tomography (CT) Scanners Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/computed-tomography-ct-scanners-devices-and-equipment-global-market-report

    Scanner Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/scanner-global-market-report

    3D Medical Imaging Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/3d-medical-imaging-devices-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • How is the Tissue Microarray Market Poised for Growth: Trends and Opportunities Through 2034

    How is the Tissue Microarray Market Poised for Growth: Trends and Opportunities Through 2034

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What fueled the previous growth in the tissue microarray market?

    In recent years, the tissue microarray market has significantly expanded. The market, which currently stands at $12.05 billion in 2024, is predicted to rise to $13.23 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.8%. The historic growth can be linked to the advancements in precision medicine, drug discovery and development, streamlined analysis, increasing occurrence of chronic illnesses, and initiatives in biobanking.

    What will be the tissue microarray market size in the future?

    Over the coming years, the tissue microarray market is forecasted to experience a swift expansion. It is projected to attain a value of $20.95 billion by 2029, boasting a compound annual growth rate (CAGR) of 12.2%. This projected growth during the estimated period can be ascribed to various factors such as the advent of digital pathology, wider applications, an expanding biopharmaceutical industry, favorable regulatory frameworks, and the incorporation of AI and machine learning. The anticipation for the forecast period encompasses advances in imaging technologies, the creation of 3D tissue microarrays, high-content screening, initiatives towards standardization, and the integration of single-cell analysis.

    Get your tissue microarray market report here!

    https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

    What main drivers are fueling expansion in the tissue microarray market?

    As cancer incidences continue to rise, it’s anticipated this will fuel enlargement of the tissue microarray market. Cancer, a group of diseases manifesting in any body organ or tissue, is characterized by erratic cell growth and invasion towards neighboring body parts or other organs. Tissue microarray is an instrumental tool in oncology for investigating the expression of cancer-associated biomarkers in a variety of tumor samples. For instance, Macmillan Cancer Support, a UK-based cancer charity, published data in June 2022 indicating that the population of individuals living with cancer had hit 3 million in 2022, forecasting a jump to approximately 3.5 million by 2025 and 4 million by 2030 in the UK. Hence, the escalating count of cancer cases is a key driver for the expansion of the tissue microarray market.

    What key areas define the segmentation of the global tissue microarray market?

    The tissue microarray market covered in this report is segmented –

    1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types

    2) By Technology: Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting

    3) By Application: Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics

    4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals

    Subsegments:

    1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry

    2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH

    3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array

    4) By Other Types: Nucleic Acid Microarrays, RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

    Who are the dominant players expanding their reach in the tissue microarray market?

    Major companies operating in the tissue microarray market include Roche Group, Merck & Co. Inc., Thermo Fisher Scientific Inc., Becton, Dickinson Biosciences, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Qiagen NV, PerkinElmer Inc., Bio-Techne Corporation, Tristar Group, Evotec SE, Precision For Medicine Inc., Molecular Devices LLC, BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co, 3DHISTECH Ltd., Novus Biologicals LLC, PREMIER Biosoft International Inc., iSpecimen Inc., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., Z Biotech LLC

    How are evolving market trends shaping tissue microarray Strategies?

    One major trend gaining traction in the tissue microarray market is the formation of strategic partnerships. There is a rising occurrence of key players in this market creating alliances to co-develop technologies related to tissue microarray. An example of this came in November 2022 when The Cureline Group, a US firm specializing in HBS biobanking and laboratory services, collaborated with Cellecta Inc., another US company providing RNAi and CRISPR screening services. This led to the launch of Tissue 2 Target Services where their respective expertise in molecular analysis of cells and tissues and human biospecimen management were fused to provide pre-clinical and translational research facilities focusing on gene target and biomarker discovery services, optimizing workflow productivity. Additionally, in September 2022, a strategic alliance was formed between Ultivue Inc., a US biotech company that designs reagent-based solutions to obtain maximum biological data from cell and tissue samples, and ngTMA, a Translational Research Unit platform from the University of Bern in Switzerland. The primary objective of this partnership is to drive the development of multiplexed immunofluorescence (mIF) assays and to implement novel TMA technology to facilitate spatial analysis in scientific study, improving the quality of TMAs used in clinical and translational research.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12236

    Which regions are emerging as leaders in the tissue microarray market?

    North America was the largest region in the tissue microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Computed Tomography (CT) Scanners Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/computed-tomography-ct-scanners-devices-and-equipment-global-market-report

    Scanner Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/scanner-global-market-report

    3D Medical Imaging Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/3d-medical-imaging-devices-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Analyzing the Future of Tissue Microarray Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities

    Analyzing the Future of Tissue Microarray Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What is the Future CAGR of the Tissue Microarray Market, and How Will It Impact Industry Expansion?

    The tissue microarray market has shown significant growth over the years. It is expected to increase from $12.05 billion in 2024 to $13.23 billion in 2025, maintaining a CAGR of 9.8%. The growth has been fueled by the rise of precision medicine, advancements in drug discovery and development, the need for efficient analysis, the increasing prevalence of chronic diseases, and growing biobanking initiatives.

    The tissue microarray market size is forecasted to expand rapidly over the next few years, growing to $20.95 billion in 2029 at a CAGR of 12.2%. Growth in this period is attributed to the rise of digital pathology, broadened applications, the expanding biopharmaceutical industry, regulatory backing and standards, and the incorporation of AI and machine learning. Major trends include advancements in imaging technologies, development of 3D tissue microarrays, high-content screening, standardization efforts, and the integration of single-cell analysis.

    What Strategic Factors Are Influencing the Accelerated Growth of the Market?

    The rising number of cancer diagnoses is expected to boost the growth of the tissue microarray market in the future. Cancer refers to a group of diseases that can emerge in any organ or tissue when abnormal cells grow uncontrollably, invade nearby body parts, and spread to other organs. Tissue microarrays are employed in oncology to analyze the expression of cancer-related biomarkers across various tumor samples. For instance, in June 2022, data from Macmillan Cancer Support, a UK-based cancer charity, revealed that the number of individuals living with cancer reached 3 million in 2022 and is projected to rise to nearly 3.5 million by 2025 and 4 million by 2030 in the UK. Therefore, the increasing number of cancer cases is advancing the tissue microarray market.

    Request Your Free Tissue Microarray Market Report Sample Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

    What Are the Top Market Players Propelling the Growth of the Tissue Microarray Industry?

    Major companies operating in the tissue microarray market include:

    • Roche Group_x000D_

    • Merck & Co. Inc._x000D_

    • Thermo Fisher Scientific Inc._x000D_

    • Becton_x000D_

    • Dickinson Biosciences_x000D_

    What Are the Key Trends to Watch in the Tissue Microarray Market Over the Coming Years?

    Strategic partnerships are emerging as a crucial trend in the tissue microarray market, with major companies forming collaborations to advance tissue microarray technology. For example, in November 2022, The Cureline Group, a US-based translational and precision medicine CRO specializing in HBS biobanking and laboratory services, partnered with Cellecta Inc., a US-based provider of RNAi and CRISPR screening products. Together, they launched Tissue 2 Target Services, a strategic alliance aimed at integrating molecular analysis of cells and tissues with human biospecimen management for gene target and biomarker discovery research. Similarly, in September 2022, Ultivue Inc., a US-based biotechnology firm, partnered with ngTMA, a Switzerland-based Translational Research Unit (TRU) at the University of Bern. This partnership focuses on enhancing multiplexed immunofluorescence (mIF) assays and developing advanced TMA technologies for clinical and translational research.

    Pre-order Your Report for Quick and Easy Delivery!

    https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

    Which Primary Segments of the Tissue Microarray Market Are Driving Growth and Industry Transformations?

    The tissue microarray market covered in this report is segmented –

    1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types

    2) By Technology: Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting

    3) By Application: Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics

    4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals

    Subsegments:

    1) By Immunohistochemistry: Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry

    2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH, Multi-Color FISH, DNA FISH

    3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array

    4) By Other Types: Nucleic Acid Microarrays, RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

    What Regions Are Dominating the Tissue Microarray Market Growth?

    North America was the largest region in the tissue microarray market in 2024. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    What Are the Defining Aspects of the Tissue Microarray Market Landscape?

    Tissue microarray refers to high-throughput technology that enables thorough analysis of an antigen’s expression across numerous tissues and cells in a single experiment using paraffin blocks or formalin. Tissue microarrays are used to simultaneously assess the protein expression of multiple tissue samples.

    Browse Through More Similar Reports By The Business Research Company:

    Computed Tomography (CT) Scanners Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/computed-tomography-ct-scanners-devices-and-equipment-global-market-report

    Scanner Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/scanner-global-market-report

    3D Medical Imaging Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/3d-medical-imaging-devices-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • 2024 Tissue Microarray Market Analysis: Market Size, Key Drivers, and Segment Insights

    2024 Tissue Microarray Market Analysis: Market Size, Key Drivers, and Segment Insights

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What Will Be the Growth Trajectory of the Tissue Microarray Market from 2024 to 2033?

    The tissue microarray industry has witnessed substantial expansion in the recent past. The growth rate is forecasted to rise from $11.17 billion in 2023 to $12.36 billion in 2024, showing a compound annual growth rate (CAGR) of 10.7%. The previous period’s surge in the market is linked to the emergence of precision medicine, advancements in drug discovery and development, effective analysis, increasing incidences of chronic ailments, and initiatives in biobanking.

    The market size of tissue microarray is projected to experience a significant surge in the next couple of years, expanding to a whopping $18.68 billion by 2028 with a compound annual growth rate (CAGR) of 10.9%. The predicted expansion in the forthcoming timeframe is mostly owing to factors like the rise of digital pathology, wider application spectrum, ascending biopharmaceutical industry, supportive regulatory norms and standards, and incorporation of AI and machine learning. Going forward, the key trends projected to reshape the forecast period encompass improvements in imaging technologies, progression in 3D tissue microarrays, advanced high-content screening, standardization efforts, and integration of single-cell analysis.

    Claim Your Free Sample of the Global Tissue Microarray Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12236&type=smp

    What Are the Primary Growth Drivers for the tissue microarray Market?

    Rise in cancer incidents is predicted to boost the growth of the tissue microarray market in the future. Cancer refers to a variety of diseases that originate in any organ or tissue when rogue cells start to multiply uncontrollably, exceeding their natural boundaries, and either invade adjacent body parts or metastasize to other organs. In the field of oncology, tissue microarrays are employed to study the expression of biomarkers related to cancer in a range of tumor samples. For example, the American Cancer Society Inc., a non-profit organization in the US, anticipates 609,820 cancer fatalities and 1,958,310 fresh cancer diagnoses in the country during 2022, as of January 2023. As a result, the escalating number of cancer situations is fuelling the expansion of the tissue microarray market.

    What Are the Defining Segments of the Tissue Microarray Market?

    1) By Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types

    2) By Technology: Deoxyribonucleic Acid (DNA) Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting, Western Blotting

    3) By Application: Oncology, Gene Expression Profiling, Single Nucleotide Polymorphism (SNP) Detection, Double-Stranded B-DNA Microarrays, Comparative Genomic Hybridization, Sequencing Bioinformatics

    4) By End-User: Pharmaceutical And Biotechnological Companies, Research Organization, Hospitals

    What Trends Are Revolutionizing Standards in the Tissue Microarray Market?

    The emergence of strategic collaborations is a significant trend within the tissue microarray market. Top-tier firms active in this sector are initiating collaborations for the establishment of new alliances aimed at developing tissue microarray technologies. For example, in November 2022, The Cureline Group, an American CRO specializing in translational and precision medicine through its HBS biobanking and lab services, joined forces with Cellecta Inc., a firm offering RNAi and CRISPR screening products and services based in the US. Their combined initiative, the Tissue 2 Target Services, intends to mesh their key proficiencies in cellular and tissue molecular analysis and human biospecimen handling to supply pre-clinical and translational research utilities. These utilities focus on the discovery of gene targets and biomarker services for efficient workflow routines. Meanwhile, in September 2022, Ultivue Inc., an American bio-tech company creating solutions for maximizing accessible biological data from cellular and tissue samples, established a partnership with ngTMA, a Swiss TRU platform under Bern University that innovates workflows for creating tissue microarray. This collaboration aims to boost the development of multiplex immunofluorescence (mIF) assays and introduce new TMA technologies, ultimately unlocking in-depth spatial analysis in scientific studies and improving the quality of TMAs applied in clinical and translational research.

    Order Now for Fast Delivery of Your Tissue Microarray Market Report!

    https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

    What Regions Are Propelling Growth in the Tissue Microarray Industry?

    North America was the largest region in the tissue microarray market in 2023. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Tissue Microarray Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the tissue microarray market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Tissue Microarray Market Include

    1. Tissue Microarray Market Executive Summary

    2. Tissue Microarray Market Segments

    3. Tissue Microarray Market Size And Template Market Growth Rate

    4. Key Tissue Microarray Market Trends

    5. Major Tissue Microarray Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Tissue Microarray Market

    26. Top Tissue Microarray Companies

    27. Tissue Microarray Market Opportunities And Strategies

    28. Tissue Microarray Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Tissue Engineering Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/tissue-engineering-global-market-report

    Facial Tissues Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/facial-tissues-global-market-report

    Cardiovascular And Soft Tissue Repair Patches Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/cardiovascular-and-soft-tissue-repair-patches-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Future Growth Forecast For The Tissue Microarray Global Market 2024-2033

    Future Growth Forecast For The Tissue Microarray Global Market 2024-2033

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

     The tissue microarray market has been experiencing rapid expansion, propelled by various factors. Here’s a closer look at its growth trajectory:

    • Historical Growth: From $11.17 billion in 2023 to $12.36 billion in 2024, boasting a CAGR of 10.7%. This growth is attributed to the rise of precision medicine, drug discovery, efficient analysis, and the prevalence of chronic diseases.
    • Forecasted Surge: Anticipated growth to $18.68 billion in 2028, with a CAGR of 10.9%. Key drivers include digital pathology, expanded applications, the biopharmaceutical industry’s growth, regulatory support, and AI integration.

    Driving Forces Behind Market Expansion

    1. Surging Cancer Cases
    • The increasing incidence of cancer acts as a significant growth catalyst.
    • Tissue arrays play a vital role in oncology, aiding in the examination of cancer-related biomarkers in tumor samples.
    • In 2022, it is estimated that the US will see 1,958,310 new cancer cases and 609,820 cancer-related deaths.

    View More On The Tissue Microarray Market Report 2024 – https://www.thebusinessresearchcompany.com/report/tissue-microarray-global-market-report

    1. Strategic Partnerships
    • Collaborations drive innovation in the tissue microarray market.
    • Partnerships like that between The Cureline Group and Cellecta Inc. aim to enhance molecular analysis and biospecimen management, offering streamlined research services.
    • Ultivue Inc. partnering with ngTMA focuses on advancing multiplexed immunofluorescence assays and applying new TMA technologies for spatial analysis.
    1. Acquisitions
    • Strategic acquisitions bolster companies’ capabilities and geographic reach.
    • BioIVT’s acquisition of Tissue Solutions Ltd expands access to high-quality biospecimens and broadens its collection network with 150 additional sites.

    Market Segmentation and Regional Outlook

    The tissue microarray market is segmented based on type, technology, application, and end-user:

    1. Type: Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types
    2. Technology: DNA Microarray, PCR, Next-Generation Sequencing, Northern Blotting, Western Blotting
    3. Application: Oncology, Gene Expression Profiling, SNP Detection, Comparative Genomic Hybridization, Sequencing Bioinformatics
    4. End-User: Pharmaceutical And Biotechnological Companies, Research Organizations, Hospitals
    • Regional Dynamics: North America dominated the market in 2023, while the Asia-Pacific region is expected to witness the fastest growth.

    Conclusion: Embracing the Future

    The tissue microarray market is poised for significant expansion, driven by technological advancements, strategic alliances, and increasing healthcare demands. With cancer cases on the rise and a growing emphasis on precision medicine, the demand for tissue arrays is set to soar. As the market evolves, stakeholders must leverage innovation and collaboration to address emerging challenges and capitalize on opportunities. By staying at the forefront of advancements, the tissue microarray market can continue to revolutionize diagnostics and therapeutics, ultimately enhancing patient outcomes worldwide.

    Request A Sample Of The Global Tissue Microarray Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=12236&type=smp